Animal Viruses
@animal-viruses.bsky.social
Home of the Comparative Virology and Viral Immunology groups at the University of Glasgow Centre for Virus Research.
Full details can be found in "Estimating population immunity to SARS-CoV-2 by random sampling from primary and secondary healthcare in Scotland, May 2024" see - tinyurl.com/EBioMedicine....
Estimating population immunity to SARS-CoV-2 by random sampling from primary and secondary healthcare in Scotland, May 2024
In the absence of systematic COVID-19 serosurveillance, random sampling of sera from
biorepositories associated with major health boards can generate valuable data about
the level of immunity in the g...
tinyurl.com
May 23, 2025 at 12:50 PM
Full details can be found in "Estimating population immunity to SARS-CoV-2 by random sampling from primary and secondary healthcare in Scotland, May 2024" see - tinyurl.com/EBioMedicine....
How do we assess COVID-19 immunity in the general population and whether current vaccines afford protection against current viral variants? Using random samples from a hospital biorepository, we assessed the effects of age, vaccine doses, and waning immunity on SARS-CoV-2 neutralisation.
May 23, 2025 at 12:50 PM
How do we assess COVID-19 immunity in the general population and whether current vaccines afford protection against current viral variants? Using random samples from a hospital biorepository, we assessed the effects of age, vaccine doses, and waning immunity on SARS-CoV-2 neutralisation.
With the ending of nationwide COVID-19 serosurveillance, our understanding of COVID-19 immunity in the general population has diminished. Vaccination is focused solely on maintaining immunity in at-risk populations; the elderly, healthcare workers, and those with weakened immune systems.
May 23, 2025 at 12:50 PM
With the ending of nationwide COVID-19 serosurveillance, our understanding of COVID-19 immunity in the general population has diminished. Vaccination is focused solely on maintaining immunity in at-risk populations; the elderly, healthcare workers, and those with weakened immune systems.
How do you track population immunity to COVID when national surveillance has ceased? A random selection of 1000 serum samples from the bio-repository of a major health board reveals valuable insights into current levels of COVID immunity.
papers.ssrn.com/sol3/papers....
papers.ssrn.com/sol3/papers....
Estimating Population Immunity to SARS-CoV-2 by Random Sampling from Primary and Secondary Healthcare
Background: As the COVID-19 pandemic has ended, the global focus has shifted from "pandemic response" to "long-term management". With no ong
papers.ssrn.com
December 30, 2024 at 3:32 PM
How do you track population immunity to COVID when national surveillance has ceased? A random selection of 1000 serum samples from the bio-repository of a major health board reveals valuable insights into current levels of COVID immunity.
papers.ssrn.com/sol3/papers....
papers.ssrn.com/sol3/papers....
Our cross-sectional study of Crimean-Congo hemorrhagic fever virus (CCHFV) in N. Tanzania revealed high seroprevalence in humans and livestock. CCHFV represents an unrecognized human health risk and should be included in differential diagnoses for febrile illness.
wwwnc.cdc.gov/eid/article/...
wwwnc.cdc.gov/eid/article/...
Crimean-Congo Hemorrhagic Fever Virus Seroprevalence in Human and Livestock Populations, Northern Tanzania
CCHFV Seroprevalence, Tanzania
wwwnc.cdc.gov
November 22, 2024 at 3:10 PM
Our cross-sectional study of Crimean-Congo hemorrhagic fever virus (CCHFV) in N. Tanzania revealed high seroprevalence in humans and livestock. CCHFV represents an unrecognized human health risk and should be included in differential diagnoses for febrile illness.
wwwnc.cdc.gov/eid/article/...
wwwnc.cdc.gov/eid/article/...